207
A 14-year-old female developed systemic lupus erythematosus (SLE)-like symptoms, rash, fever, leukopenia and positive anti-nuclear antibody (ANA) two weeks after administration of carbamazepine (CBZ; Tegretol) used against benign Rolandic epilepsy.
 ( adverse event: developed ,  A 14-year-old female: Subject, 14-year-old: Subject.Age, female: Subject.Gender, systemic lupus erythematosus (SLE)-like symptoms, rash, fever, leukopenia and positive anti-nuclear antibody (ANA): Effect, administration of carbamazepine (CBZ; Tegretol) used against benign Rolandic epilepsy: Treatment, carbamazepine: Treatment.Drug, benign Rolandic epilepsy: Treatment.Disorder) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: developed ,  A 14-year-old female: Subject, 14-year-old: Subject.Age, female: Subject.Gender, systemic lupus erythematosus (SLE)-like symptoms, rash, fever, leukopenia and positive anti-nuclear antibody (ANA): Effect, administration of carbamazepine (CBZ; Tegretol) used against benign Rolandic epilepsy: Treatment, carbamazepine: Treatment.Drug, benign Rolandic epilepsy: Treatment.Disorder) 